AGS-v PLUS, a Mosquito Salivary Peptide Vaccine, Modulates the Response to <i>Aedes</i> Mosquito Bites in Humans

Background: The global health burden of mosquito-borne viruses, including dengue, yellow fever, Zika, and chikungunya, is rising due to climate change and globalisation, which favour mosquito habitat expansion. The genetic diversity of these viruses complicates the development of virus-specific vacc...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Liam Barningham, Ian M. Carr, Siân Jossi, Megan Cole, Aiyana Ponce, Mara Short, Claudio Meneses, Joshua R. Lacsina, Jesus G. Valenzuela, Fabiano Oliveira, Matthew B. Laurens, DeAnna J. Friedman-Klabanoff, Olga Pleguezuelos, Lucy F. Stead, Clive S. McKimmie
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	MDPI AG 2025-09-01
Sarja:	Vaccines
Aiheet:	arbovirus vaccine skin mosquito RNA-seq saliva
Linkit:	https://www.mdpi.com/2076-393X/13/10/1026
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!